Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Download PDF
Synthesis 2024; 56(14): 2234-2238
DOI: 10.1055/a-2235-5080
DOI: 10.1055/a-2235-5080
paper
Short Synthesis of Dopamine Agonist Rotigotine
The authors thank the Council of Scientific and Industrial Research (CSIR), C.S. thanks the University Grants Commission (UGC), and SK thanks CSIR for a research fellowship. S. C. thanks the Science and Engineering Research Board (SERB), Government of India for J C Bose fellowship (SB/S2/JCB-002/2015).
Abstract
A practical and short synthesis of FDA approved drug, Rotigotine, is achieved in two steps from 5-methoxy-2-tetralone, which in turn was synthesised by [4+2] cycloaddition of the in situ generated methoxyaryne from its precursor aryl triflate with benzyloxybutadiene or from 4-methoxyindanone via ring expansion using trimethylsilyldiazomethane.
Supporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/a-2235-5080.
- Supporting Information
Publication History
Received: 10 November 2023
Accepted after revision: 27 December 2023
Accepted Manuscript online:
27 December 2023
Article published online:
29 January 2024
© 2024. Thieme. All rights reserved
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1a Kolster KS, Kohnen R, Schollmayer E, Moller JC, Oertel WH. Mov. Disord. 2004; 19: 1432
- 1b Gorgoraptis N, Mah YH, Machner B, Curry VS, Malhotra P, Michael MH, Cohen D, Simister R, Nair A, Kulinskaya E, Ward N, Greenwood R, Husain M. Brain 2012; 135: 2478
- 2 Wilson SM, Wurst MG, Whatley MF, Daniels RN. ACS Chem. Neurosci. 2020; 11: 2506
- 3 Trenkwalder C, Borreguero DG, Montagna P, Lainey E, de Weerd AW, Tidswell P, Zyhlarz GS, Telstad W, Strambi LF. J. Neurol. Neurosurg. Psychiatry 2004; 75: 92
- 4a Park DY, Kim KH, Cheon CH. Adv. Synth. Catal. 2018; 360: 462
- 4b Webster R, Boyer A, Fleming MJ, Lautens M. Org. Lett. 2010; 12: 5148
- 4c Citoler J, Harawa V, Marshall JR, Bevinakatti H, Finnigan JD, Charnock SJ, Turner NJ. Angew. Chem. Int. Ed. 2021; 60: 24456
- 5 Zhou CQ, Li SS, Chen ZM, Li FQ, Lei P, Peng GG. PLoS One 2013; 8: e69738
- 6a Venkatesh T, Mainkar PS, Chandrasekhar S. Org. Biomol. Chem. 2019; 17: 2192
- 6b Chandrasekhar S, Reddy MV. Tetrahedron 2000; 56: 1111
- 6c Anugu RR, Mainkar PS, Sridhar B, Chandrasekhar S. Org. Biomol. Chem. 2016; 14: 1332
- 7a Krel M, Lallemand JY, Guillou C. Synlett 2005; 2043
- 7b Cobley CJ, Evans G, Fanjul T, Simmonds S, Woods A. Tetrahedron Lett. 2016; 57: 986
- 8a He X, Guo J, Wang Y, Tang W, Zhang X, Wang X, Wang Y. Patent WO2011/026318, 2011
- 8b Olondriz FM, Marco MP. Patent US 2011/0152543 A1, 2011
- 9a Chen T, Zou Y, Hu Y, Zhang Z, Wei H, Wei L, Zhang W. Angew. Chem. Int. Ed. 2023; 62: e202303488
- 9b Salomy E, Orgue S, Riera A, Verdaguer X. Angew. Chem. Int. Ed. 2016; 55: 798
- 10a Comprehensive Aryne Synthetic Chemistry . Yoshida H. Elsevier; Amsterdam: 2022
- 10b Bhojgude SS, Bhunia A, Biju AT. Acc. Chem. Res. 2016; 49: 1658
- 10c Nagai A, Kobayashi A, Sakata Y, Minami Y, Uchida K, Hosoya T, Yoshida S. Synthesis 2022; 54: 5017
- 10d Rai S, Samath P, Addipilli R, Mainkar PS, Sripadi P, Adepu R, Chandrasekhar S. Synthesis 2022; 54: 5026
- 10e Zhang R, Peng X, Tan J. Synthesis 2022; 54: 5064
- 10f George J, Ward JS, Sherburn MS. Org. Lett. 2019; 21: 7529
- 11a Wu C, Fang Y, Larock RC, Shi F. Org. Lett. 2010; 12: 2234
- 11b Li X, Sun Y, Huang X, Zhang L, Kong L, Peng B. Org. Lett. 2017; 19: 838
- 11c Roy T, Biju AT. Chem. Commun. 2018; 54: 2580
- 12 Liu C, Deng G, Li X, Xu Y, Yu K, Chen W, Zhang H, Yang X. Eur. J. Org. Chem. 2020; 20: 483
- 13 Liu W, Buck M, Chen N, Shang M, Taylor NJ, Asoud J, Wu X, Hasinoff BB, Dmitrienko GI. Org. Lett. 2007; 9: 2915